Corteva, Inc. $CTVA Shares Sold by Benjamin Edwards Inc.

Key Points

• Benjamin Edwards Inc. cut its Corteva stake by 11.5% in the second quarter, selling 80,608 shares and retaining 620,922 shares worth approximately $52.6 million. Institutional investors collectively own 81.54% of Corteva.
• Corteva reported quarterly EPS of $2.30, beating estimates of $2.24, while revenue of $6.38 billion fell short of forecasts and declined 1.2% year over year. The company maintained fiscal 2026 EPS guidance of $3.60–$3.80.
• The company declared a quarterly dividend of $0.18 per share, equivalent to an annualized $0.72 payout and a 0.9% yield. Analysts maintain a “Moderate Buy” consensus with an average price target of $91.50.

Benjamin Edwards Inc. reduced its holdings in Corteva, Inc. (NYSE:CTVA - Free Report) by 11.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 620,922 shares of the company's stock after selling 80,608 shares during the quarter. Benjamin Edwards Inc. owned 0.09% of Corteva worth $52,586,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new position in Corteva in the 2nd quarter valued at about $4,560,180,000. State Street Corp increased its stake in shares of Corteva by 3.7% during the fourth quarter. State Street Corp now owns 36,570,876 shares of the company's stock valued at $2,451,346,000 after acquiring an additional 1,290,071 shares during the period. Franklin Resources Inc. raised its holdings in Corteva by 4.3% during the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company's stock worth $1,309,599,000 after purchasing an additional 805,873 shares in the last quarter. Harris Associates L P lifted its position in Corteva by 168.1% in the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company's stock worth $1,141,268,000 after purchasing an additional 10,675,052 shares during the period. Finally, Northern Trust Corp boosted its stake in Corteva by 5.0% during the 4th quarter. Northern Trust Corp now owns 11,731,834 shares of the company's stock valued at $786,385,000 after purchasing an additional 562,550 shares in the last quarter. Institutional investors and hedge funds own 81.54% of the company's stock.

Corteva Price Performance

CTVA stock opened at $84.00 on Friday. Corteva, Inc. has a one year low of $60.53 and a one year high of $90.97. The firm has a 50-day moving average of $82.69 and a two-hundred day moving average of $80.54. The firm has a market capitalization of $56.04 billion, a PE ratio of 55.63, a P/E/G ratio of 2.58 and a beta of 0.57. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The firm's revenue was down 1.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, analysts forecast that Corteva, Inc. will post 3.72 earnings per share for the current year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be issued a dividend of $0.18 per share. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva's payout ratio is currently 47.68%.

Analyst Ratings Changes

A number of analysts have recently commented on the company. Jefferies Financial Group boosted their price objective on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Weiss Ratings cut shares of Corteva from a "hold (c+)" rating to a "hold (c)" rating in a research report on Monday, August 3rd. JPMorgan Chase & Co. upped their price target on shares of Corteva from $77.00 to $83.00 and gave the company a "neutral" rating in a report on Monday, August 3rd. Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $101.00 price objective on shares of Corteva in a research report on Monday, August 3rd. Finally, Citigroup boosted their target price on shares of Corteva from $85.00 to $86.00 and gave the stock a "neutral" rating in a report on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company's stock. According to MarketBeat, Corteva currently has a consensus rating of "Moderate Buy" and a consensus price target of $91.50.

Corteva Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source